NASDAQ:AFIB Acutus Medical (AFIB) Stock Price, News & Analysis $0.05 0.00 (-7.59%) As of 02/21/2025 03:54 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsTrends About Acutus Medical Stock (NASDAQ:AFIB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Acutus Medical alerts:Sign Up Key Stats Today's Range$0.05▼$0.0650-Day Range$0.04▼$0.0752-Week Range$0.03▼$0.27Volume48,095 shsAverage Volume48,442 shsMarket Capitalization$1.60 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewAcutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.Read More… Receive AFIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AFIB Stock News HeadlinesAcutus Medical Announces Operational DownsizingDecember 4, 2024 | globenewswire.comAcutus Medical Reports Q3 2024 Financial ResultsNovember 20, 2024 | markets.businessinsider.comShocking Elon Move: Bigger than DOGE?After saving free speech with his acquisition of Twitter… And after blowing everyone’s minds with his recent DOGE moves… What Elon Musk is about to do next could not only shock the world… But also put an extra $30,000 a year in your pocket.February 22, 2025 | Brownstone Research (Ad)Study reveals COVID-19 vaccine safety in patients with atrial fibrillation/flutterNovember 14, 2024 | msn.comAcutus Medical Reports Third Quarter and Year-To-Date 2024 Financial ResultsNovember 14, 2024 | globenewswire.comExtra hour of weekly exercise reduces risk of atrial fibrillationNovember 12, 2024 | msn.comThe Apple Watch is helping Afib patients ditch blood thinners in a ground-breaking trialNovember 8, 2024 | msn.comECU Health introduces new procedure to help patients with Atrial FibrillationOctober 28, 2024 | msn.comSee More Headlines AFIB Stock Analysis - Frequently Asked Questions How have AFIB shares performed this year? Acutus Medical's stock was trading at $0.0550 at the start of the year. Since then, AFIB shares have decreased by 2.5% and is now trading at $0.0536. View the best growth stocks for 2025 here. How were Acutus Medical's earnings last quarter? Acutus Medical, Inc. (NASDAQ:AFIB) posted its quarterly earnings data on Thursday, November, 11th. The company reported ($0.94) EPS for the quarter, missing analysts' consensus estimates of ($0.92) by $0.02. The company earned $4.60 million during the quarter, compared to analyst estimates of $6.02 million. Acutus Medical had a negative net margin of 272.74% and a negative trailing twelve-month return on equity of 311.64%. Does Acutus Medical have any subsidiaries? Acutus Medical subsidiaries include these companies: Acutus Medical N.V.. When did Acutus Medical IPO? Acutus Medical (AFIB) raised $126 million in an initial public offering (IPO) on Thursday, August 6th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. How do I buy shares of Acutus Medical? Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Acutus Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Acutus Medical investors own include Enterprise Products Partners (EPD), NVIDIA (NVDA), Arista Networks (ANET), Meta Platforms (META), Nextera Energy Partners (NEP), PayPal (PYPL) and Rio Tinto Group (RIO). Company Calendar Last Earnings11/11/2021Today2/22/2025Next Earnings (Estimated)3/31/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:AFIB CUSIPN/A CIK1522860 Webwww.acutusmedical.com Phone442-232-6080Fax442-232-6081Employees340Year Founded2011Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-81,660,000.00 Net Margins-272.74% Pretax Margin-30.32% Return on Equity-311.64% Return on Assets-11.57% Debt Debt-to-Equity RatioN/A Current Ratio1.85 Quick Ratio1.57 Sales & Book Value Annual Sales$7.16 million Price / Sales0.22 Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / Book-1.79Miscellaneous Outstanding Shares29,780,000Free Float28,228,000Market Cap$1.60 million OptionableOptionable Beta-0.18 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (NASDAQ:AFIB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored(1) Elon Musk’s Final Project REVEALEDThe world’s richest man has an ace up his sleeve. You see, while everyone is talking about Elon Musk’s plan...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acutus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acutus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.